NovaBay Pharmaceuticals, Inc. (NBY)

0.0896 +0.0088 (+10.89%) At close: 04:00PM EDT

NovaBay Pharmaceuticals, Inc.

2000 Powell Street
Suite 1150, eleventh floor
Emeryville, CA 94608
United States
510 899 8800
https://novabay.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 24

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Justin M. Hall Esq.	President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director	364.15k	N/A	1978
Mr. Tommy Law	Controller, Interim CFO & Treasurer	177.7k	N/A	1985

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Corporate governance

NovaBay Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.